Ductal carcinoma in situ of the breast, report of 430 cases
10.3760/cma.j.issn.1007-631X.2013.11.013
- VernacularTitle:430例乳腺导管内癌临床分析
- Author:
Man LIN
;
Fengli GUO
;
Lijuan WEI
;
Shanshan ZHU
;
Jing ZHAO
;
Juntian LIU
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Carcinoma,intraductal,noninfiltrating;
Prognosis
- From:
Chinese Journal of General Surgery
2013;28(11):857-860
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical characteristics,treatment and prognosis of ductal carcinoma in situ of the breast.Methods We retrospectively analysed 430 patients with a diagnosis of DCIS in Cancer Hospital of Tianjin Medical University from January 1991 to December 2005,to evaluate the clinical characteristics,treatment and prognosis.Results Overall survival rate of 430 patients was 94.9％ (408/430).10 cases died of breast cancer recurrence,7 for local recurrence,3 for metastsis.Tumor size,TNM stages and structural pattern of pathlogy were prognosis impacting factors (P ＜ 0.05).The 5-year survival rate for combination radiotherapy and breast-conserving surgery group was 100％,and 10-year survival rate was 97.1％,comparing traditional modified radical mastectomy 5-year survival rate of 98.3％and 10-year survival of 96.7％ (P ＞ 0.05).The overall survival rate of surgery alone group (89.9％) was lower than the post-operative comprehensive treatment group (96.8％),(P ＜ 0.05).Conclusions Treatment of DCIS should be based on primary tumor's clinical stage and histologic characters.Breast-conserving surgery enjoys the same outcome as traditional modified radical mastectomy.
